AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29523124 — intervention group
Group type: EXPERIMENTAL
Intervention: Dream School Program (DSP) only
Number of subjects: 17
Study 29523124 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (offered DSP intervention in 2018/2019)
Number of subjects: 17
Study 26905932 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-sharing counselling intervention for maternal depression (details on dosage and duration not available)
Number of subjects: 21
Study 26905932 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative semi-structured interviews
Number of subjects: 21
Study 26160062 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Hemoperfusion + Hemodialysis (HP + HD)
Number of subjects: 36
Study 26160062 — intervention group
Group type: COMPARATOR
Intervention: Hemodialysis (HD) alone
Number of subjects: 36
Study 22546716 — intervention group
Group type: EXPERIMENTAL
Intervention: Incorporating 60 g/day whole grains into the diet for 16 weeks
Number of subjects: 0
Study 22546716 — intervention group
Group type: EXPERIMENTAL
Intervention: Incorporating 60 g/day whole grains into the diet for 8 weeks, doubling to 120 g/day for the following 8 weeks
Number of subjects: 0
Study 22546716 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 20193253 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline delivered via remote controlled capsule to the small bowel
Number of subjects: 12
Study 20193253 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline delivered via remote controlled capsule to the ascending colon
Number of subjects: 12
Study 20193253 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline delivered orally (control)
Number of subjects: 12
Study 18577477 — intervention group
Group type: EXPERIMENTAL
Intervention: Urso treatment
Number of subjects: 12
Study 18577477 — intervention group
Group type: COMPARATOR
Intervention: Control (no urso treatment)
Number of subjects: 12
Study 16157621 — intervention group
Group type: COMPARATOR
Intervention: VACOP-B for 12 weeks (plus HDS/HDT in case of persistent disease)
Number of subjects: 223
Study 16157621 — intervention group
Group type: EXPERIMENTAL
Intervention: VACOP-B for 8 weeks plus upfront HDS/HDT
Number of subjects: 223
Study 12233894 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg
Number of subjects: 635
Study 12233894 — intervention group
Group type: COMPARATOR
Intervention: Alendronate 10 mg
Number of subjects: 635
Study 10091757 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery after receiving 30 gray of RT
Number of subjects: 20
Study 10091757 — intervention group
Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 20
Study 7490141 — intervention group
Group type: EXPERIMENTAL
Intervention: copper-zinc superoxide dismutase (6000 U/min)
Number of subjects: 20
Study 7490141 — intervention group
Group type: COMPARATOR
Intervention: sodium nitroprusside
Number of subjects: 20
Study 2258874 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual education
Number of subjects: 722
Study 2258874 — intervention group
Group type: EXPERIMENTAL
Intervention: Team education
Number of subjects: 722
Study 2258874 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 722
Study 6122100 — intervention group
Group type: EXPERIMENTAL
Intervention: GL enzyme (hyaluronidase preparation)
Number of subjects: 192
Study 6122100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 30879212 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Housing Placement Assistance (EHPA)
Number of subjects: 236
Study 30879212 — intervention group
Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 236
Study 27956016 — intervention group
Group type: EXPERIMENTAL
Intervention: GC Gold Label 9 (GC Corp)
Number of subjects: 150
Study 27956016 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitro Molar (DFL)
Number of subjects: 150
Study 27956016 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxxion R (FGM)
Number of subjects: 150
Study 26220945 — intervention group
Group type: EXPERIMENTAL
Intervention: YesB (breakfast, lunch, and dinner)
Number of subjects: 22
Study 26220945 — intervention group
Group type: COMPARATOR
Intervention: NoB (lunch and dinner without breakfast)
Number of subjects: 22
Study 25711716 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin-impregnated collagen sponge
Number of subjects: 50
Study 25711716 — intervention group
Group type: COMPARATOR
Intervention: Control (excision and marsupialization without gentamicin sponge)
Number of subjects: 50
Study 21852609 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 260
Study 19410397 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement restrictions after a single Epley maneuver
Number of subjects: 64
Study 19410397 — intervention group
Group type: COMPARATOR
Intervention: Free movements after a single Epley maneuver
Number of subjects: 64
Study 21070621 — intervention group
Group type: EXPERIMENTAL
Intervention: RSI QuickScan intervention programme
Number of subjects: 638
Study 21070621 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 638
Study 16109909 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal dysphagia screen
Number of subjects: 2532
Study 16109909 — intervention group
Group type: COMPARATOR
Intervention: No formal dysphagia screen
Number of subjects: 2532
Study 12375683 — intervention group
Group type: EXPERIMENTAL
Intervention: nifedipine 10 mg orally every 4 h
Number of subjects: 116
Study 12375683 — intervention group
Group type: COMPARATOR
Intervention: no prophylaxis (control)
Number of subjects: 116
Study 9928780 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil 5 mg
Number of subjects: 30
Study 9928780 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 30
Study 7567428 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal-signal detection task with feedback
Number of subjects: 0
Study 7567428 — intervention group
Group type: COMPARATOR
Intervention: Temporal-signal detection task without feedback
Number of subjects: 0
Study 7567428 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection task with 12 s target
Number of subjects: 0
Study 7567428 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection task with 5, 10, or 15 s targets
Number of subjects: 0
Study 2268917 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenshao Tongguan Pian (SSTGP)
Number of subjects: 565
Study 2268917 — intervention group
Group type: COMPARATOR
Intervention: Dan Qi Pian (control)
Number of subjects: 565
Study 6107159 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 96
Study 6107159 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam
Number of subjects: 96
Study 6107159 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 31145173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propofol 1 to 2 mg/kg pretreatment to deepen anesthesia to BIS<40
Number of subjects: 120
Study 31145173 — intervention group
Group type: COMPARATOR
Intervention: Control group - intravenous saline pretreatment before PCTG puncture and anesthesia targeted to BIS 40 to 60
Number of subjects: 120
Study 31145173 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group - intravenous propofol 1 to 2 mg/kg pretreatment
Number of subjects: 120
Study 31145173 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 30286558 — intervention group
Group type: EXPERIMENTAL
Intervention: α-Lipoic Acid (ALA) 900 mg daily for 10 days
Number of subjects: 80
Study 30286558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 27263400 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced messaging emphasizing safe sleep practices for both SIDS risk reduction and suffocation prevention
Number of subjects: 1194
Study 27263400 — intervention group
Group type: COMPARATOR
Intervention: Standard messaging emphasizing safe sleep practices recommended by the American Academy of Pediatrics for SIDS risk reduction
Number of subjects: 1194
Study 24352340 — intervention group
Group type: EXPERIMENTAL
Intervention: udenafil 100 mg/day
Number of subjects: 29
Study 24352340 — intervention group
Group type: COMPARATOR
Intervention: amlodipine 10 mg/day
Number of subjects: 29
Study 22717670 — intervention group
Group type: EXPERIMENTAL
Intervention: CDUS (Colour Duplex Ultrasound) as the first line surveillance tool
Number of subjects: 145
Study 22717670 — intervention group
Group type: COMPARATOR
Intervention: CT (Computed Tomography)
Number of subjects: 145
Study 22717670 — intervention group
Group type: COMPARATOR
Intervention: CDUS vs CT for measuring residual aneurysm size
Number of subjects: 145
Study 20029053 — intervention group
Group type: EXPERIMENTAL
Intervention: Video self-modeling (VSM) following speech restructuring treatment
Number of subjects: 89
Study 20029053 — intervention group
Group type: COMPARATOR
Intervention: Standard maintenance (control group)
Number of subjects: 89
Study 18721639 — intervention group
Group type: EXPERIMENTAL
Intervention: State worry condition
Number of subjects: 0
Study 18721639 — intervention group
Group type: COMPARATOR
Intervention: Relaxation condition
Number of subjects: 0
Study 16280763 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg
Number of subjects: 102
Study 16280763 — intervention group
Group type: COMPARATOR
Intervention: Bicalutamide 150 mg + Tamoxifen 10 mg
Number of subjects: 102
Study 16280763 — intervention group
Group type: COMPARATOR
Intervention: Bicalutamide 150 mg + Radiotherapy (RT)
Number of subjects: 102
Study 12442242 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot-water immersion (40-41 degrees C)
Number of subjects: 25
Study 12442242 — intervention group
Group type: COMPARATOR
Intervention: Comparison treatment (papain or vinegar)
Number of subjects: 25
Study 12442242 — intervention group
Group type: COMPARATOR
Intervention: Hot-water immersion vs Comparison treatment
Number of subjects: 25
Study 10624639 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 100 micrograms loading dose and 70 micrograms.h‐1 continuous infusion
Number of subjects: 65
Study 10624639 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 200 micrograms loading dose and 150 micrograms.h‐1 continuous infusion
Number of subjects: 65
Study 10624639 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O concentrations of 0, 20, 40, and 60 vol%; additionally 75 vol% N2O in the group without fentanyl
Number of subjects: 65
Study 10624639 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane vaporizer settings to maintain median power frequency between 2 Hz and 3 Hz
Number of subjects: 65
Study 7723650 — intervention group
Group type: EXPERIMENTAL
Intervention: Supramaximal all-out exercise at 149% VO2max (study 1)
Number of subjects: 21
Study 7723650 — intervention group
Group type: COMPARATOR
Intervention: Constant intensity exercise at approximately 110% VO2max (study 2)
Number of subjects: 21
Study 1974686 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol (12 micrograms inhalation b.i.d.)
Number of subjects: 301
Study 1974686 — intervention group
Group type: COMPARATOR
Intervention: salbutamol (200 micrograms inhalation q.i.d.)
Number of subjects: 301
Study 1974686 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol
Number of subjects: 301
Study 1974686 — intervention group
Group type: COMPARATOR
Intervention: salbutamol
Number of subjects: 301
Study 7426230 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric solution (10 mg amethocaine)
Number of subjects: 60
Study 7426230 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric solution (15 mg amethocaine)
Number of subjects: 60
Study 7426230 — intervention group
Group type: COMPARATOR
Intervention: Isobaric solution (10 mg amethocaine)
Number of subjects: 60
Study 7426230 — intervention group
Group type: COMPARATOR
Intervention: Isobaric solution (15 mg amethocaine)
Number of subjects: 60
Study 7426230 — intervention group
Group type: COMPARATOR
Intervention: Hypobaric solution (10 mg amethocaine)
Number of subjects: 60
Study 7426230 — intervention group
Group type: COMPARATOR
Intervention: Hypobaric solution (15 mg amethocaine)
Number of subjects: 60
Study 7426230 — intervention group
Group type: EXPERIMENTAL
Intervention: Amethocaine 15 mg
Number of subjects: 60
Study 7426230 — intervention group
Group type: EXPERIMENTAL
Intervention: Amethocaine 10 mg
Number of subjects: 60
Study 31163134 — intervention group
Group type: EXPERIMENTAL
Intervention: Large cup‐to‐disc ratio (greater than 0.6)
Number of subjects: 1636
Study 31163134 — intervention group
Group type: COMPARATOR
Intervention: No large cup‐to‐disc ratio
Number of subjects: 1636
Study 31163134 — intervention group
Group type: EXPERIMENTAL
Intervention: Large cup‐to‐disc ratio
Number of subjects: 1636
Study 29436314 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual-assisted staff training in positive behaviour support (PBS)
Number of subjects: 246
Study 29436314 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 246
Study 26826432 — intervention group
Group type: COMPARATOR
Intervention: Standard settings of the Fenwal Amicus Apheresis system (mononuclear cells offset of 1.5 and RBC offset of 5.0)
Number of subjects: 122
Study 26826432 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified settings of the Fenwal Amicus Apheresis system (mononuclear cells offset of 1.5 and RBC offset of 6.0)
Number of subjects: 122
Study 26826432 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐ALC < .5 × 10(9) lymphocytes/kg
Number of subjects: 122
Study 26826432 — intervention group
Group type: EXPERIMENTAL
Intervention: A‐ALC ≥ .5 × 10(9) lymphocytes/kg
Number of subjects: 122
Study 24678066 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar diathermy
Number of subjects: 27
Study 24678066 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle patch
Number of subjects: 27
Study 24678066 — intervention group
Group type: EXPERIMENTAL
Intervention: Aneurysm clip
Number of subjects: 27
Study 22464581 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood glucose control (group A, n = 35)
Number of subjects: 102
Study 22464581 — intervention group
Group type: EXPERIMENTAL
Intervention: Active blood glucose control (group B, n = 38)
Number of subjects: 102
Study 22464581 — intervention group
Group type: COMPARATOR
Intervention: Common glucose control (group C, n = 29)
Number of subjects: 102
Study 19715451 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser technique
Number of subjects: 43
Study 19715451 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery using a scalpel
Number of subjects: 43
Study 18502162 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human arylsulfatase B (rhASB) at 1 mg/kg weekly infusions
Number of subjects: 56
Study 18502162 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human arylsulfatase B (rhASB)
Number of subjects: 56
Study 18502162 — intervention group
Group type: COMPARATOR
Intervention: placebo/rhASB
Number of subjects: 56
Study 15895275 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous IFNbeta‐1b (Betaferon) treatment
Number of subjects: 40
Study 15895275 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 40
Study 12233808 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger syrup (1 tablespoon in 4 to 8 ounces of hot or cold water, 4 times daily)
Number of subjects: 26
Study 12233808 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup (1 tablespoon in 4 to 8 ounces of hot or cold water, 4 times daily)
Number of subjects: 26
Study 12233808 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger syrup
Number of subjects: 26
Study 12233808 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 26
Study 9705036 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (blood lactate threshold exercise using a cycle ergometer for 60 min three times a week for 4 weeks)
Number of subjects: 29
Study 9705036 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 29
Study 9705036 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise (control group)
Number of subjects: 29
Study 7778813 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporine 1
Number of subjects: 0
Study 7778813 — intervention group
Group type: COMPARATOR
Intervention: Cephalosporine 1 (5-day administration)
Number of subjects: 0
Study 7778813 — intervention group
Group type: COMPARATOR
Intervention: Cephalosporine 2 (2-day treatment)
Number of subjects: 0
Study 7778813 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics for clean, planned surgery (grade II)
Number of subjects: 0
Study 2531557 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms.kg‐1 sufentanil as an induction dose plus 0.15 microgram.kg‐1.min‐1 continuous infusion
Number of subjects: 20
Study 2531557 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms.kg‐1 sufentanil as an induction dose plus 0.3 microgram.kg‐1.min‐1 continuous infusion
Number of subjects: 20
Study 2531557 — intervention group
Group type: COMPARATOR
Intervention: Control values during sternotomy
Number of subjects: 20
Study 2531557 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG analysis during sufentanil anesthesia
Number of subjects: 20
Study 1078528 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive nutrition consultation
Number of subjects: 300
Study 1078528 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 300
Study 31253252 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 100
Study 31253252 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Manipulation Therapy (SMT)
Number of subjects: 100
Study 25378096 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard physiotherapy plus visceral manipulation
Number of subjects: 64
Study 25378096 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy plus placebo visceral manipulation
Number of subjects: 64
Study 24369785 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention and physical training (fluid intake, protein and energy intake, strength training, increasing baseline activities)
Number of subjects: 80
Study 24369785 — intervention group
Group type: COMPARATOR
Intervention: Home visits without any intervention
Number of subjects: 80
Study 21575503 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT‐11 + CAP (irinotecan plus capecitabine)
Number of subjects: 63
Study 21575503 — intervention group
Group type: COMPARATOR
Intervention: L‐OHP + CAP (oxaliplatin plus capecitabine)
Number of subjects: 63
Study 18022709 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric care unit
Number of subjects: 143
Study 16626718 — intervention group
Group type: EXPERIMENTAL
Intervention: Drape estimation of blood loss
Number of subjects: 123
Study 16626718 — intervention group
Group type: COMPARATOR
Intervention: Visual estimation of blood loss
Number of subjects: 123
Study 15119989 — intervention group
Group type: EXPERIMENTAL
Intervention: GAL 24 mg (12 mg BID)
Number of subjects: 1698
Study 15119989 — intervention group
Group type: EXPERIMENTAL
Intervention: GAL 16 mg (8 mg BID)
Number of subjects: 1698
Study 15119989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1698
Study 11574383 — intervention group
Group type: EXPERIMENTAL
Intervention: Puncture of the cephalic vein 12 cm or more proximal to the styloid process of the radius
Number of subjects: 33
Study 11574383 — intervention group
Group type: COMPARATOR
Intervention: Cephalic vein puncture at random locations
Number of subjects: 33
Study 9773664 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirilazad mesylate 6 mg/kg/day for 10 days
Number of subjects: 1023
Study 9773664 — intervention group
Group type: COMPARATOR
Intervention: Vehicle treatment
Number of subjects: 1023
Study 8064733 — intervention group
Group type: EXPERIMENTAL
Intervention: S-adenosylmethionine (SAM) intravenous boluses of 400 mg for 5 days, followed by oral tablets, 200 mg thrice daily for 23 days
Number of subjects: 81
Study 8064733 — intervention group
Group type: COMPARATOR
Intervention: Placebo regimen
Number of subjects: 81
Study 3069750 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenticonazole vaginal ovules 200 mg
Number of subjects: 42
Study 3069750 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenticonazole vaginal ovules 600 mg
Number of subjects: 42
Study 3069750 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenticonazole vaginal ovules 1,000 mg
Number of subjects: 42
Study 31687884 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient multidisciplinary rehabilitation (MDR)
Number of subjects: 427
Study 31075662 — intervention group
Group type: COMPARATOR
Intervention: Control downhill running at -6 degrees inclination (CON-6)
Number of subjects: 40
Study 31075662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadence -10%
Number of subjects: 40
Study 31075662 — intervention group
Group type: COMPARATOR
Intervention: Control normal level running at 0 degrees inclination (CON-0)
Number of subjects: 40
Study 31075662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadences +/5%
Number of subjects: 40
Study 29078966 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) on PC6 acupuncture point
Number of subjects: 40
Study 29078966 — intervention group
Group type: COMPARATOR
Intervention: Control group (steps reversed)
Number of subjects: 40
Study 25330466 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion intervention (food planning plus self-compassion exercises)
Number of subjects: 41
Study 25330466 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviourally based intervention (food planning plus behavioural strategies)
Number of subjects: 41
Study 25330466 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 41
Study 23680007 — intervention group
Group type: EXPERIMENTAL
Intervention: Steamed bread made from Jizi439
Number of subjects: 20
Study 23680007 — intervention group
Group type: COMPARATOR
Intervention: Mixture of white grain bread wheat
Number of subjects: 20
Study 23680007 — intervention group
Group type: COMPARATOR
Intervention: Buckwheat
Number of subjects: 20
Study 23680007 — intervention group
Group type: COMPARATOR
Intervention: Steamed bread made from Chu20
Number of subjects: 20
Study 22104156 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved-field irradiation (IFI)
Number of subjects: 102
Study 18275361 — intervention group
Group type: EXPERIMENTAL
Intervention: Compressed air massage (15-20 min daily at 1 bar pressure, 5 days a week)
Number of subjects: 60
Study 18275361 — intervention group
Group type: COMPARATOR
Intervention: Standard medical and surgical management
Number of subjects: 60